Global Health Technologies Coalition’s “Breakthroughs”: The R&D agenda and how it addresses access to vaccines
“In this guest post, Dr. Jayasree K. Iyer — chief scientific officer at the Access to Medicine Foundation — writes about the findings from their newest study, which examines the current state of the vaccine pipeline and how large pharmaceutical companies are considering access to these products” (Chmiola, 10/20).